This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma Gets 5 USFDA Observations for Unit-IV FacilityAurobindo Pharma Extends Timeline to Acquire 26% in Swarnaakshu Solar
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceDelhi HC restrains Dr Reddy's from manufacturing VENUSIA sunscreens with SUN label
Indian Pharmacopoeia 2026 Adds 121 New Monographs Including Blood Component StandardsIndian Pharmacopoeia 2026 Adds 121 New Monographs Including Blood Component Standards
Senior IAS Officer Manoj Joshi Takes Charge as Pharma SecretaryLeadership Change at DoP: Senior IAS Officer Manoj Joshi Takes Charge as Pharma Secretary
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, GemcitabineNPPA Committee Caps Price of Akums' Cetirizine Eye Drops at Rs 14.42 per ml
Torrent Pharma Gets Zero USFDA Observations for Dahej PlantSetback to Corcept Therapeutics: USFDA Declines Approval for Relacorilant in Cushing's-Linked...
Alkem Gets EU GMP Compliance Certificate for Daman Facility from Malta AuthorityAlkem Labs Receives Rs 9.72 Lakh GST Demand for FY 2021-22
Apollo Hospitals Acquires 51% Stake in Healthtech Startup to Boost Digital Healthcare ServicesApollo Hospitals Acquires 51% Stake in Healthtech Startup to Boost Digital Healthcare Services
WHO Alert Spurs Indias Probe Into Deadly Cough Syrup, Licence Cancelled, 700 Plus Units Audited, Parliament InformedGovt Proposes Stricter Controls on Syrups, Seeks Removal From Schedule K
Haryana Flags Over 30 Drug Overcharging Cases, Seeks NPPA ActionDespite Price Caps, Pharma Firms Overcharged Patients by Rs 10,000+ Cr: NPPA
Aurobindo Pharma Gets 11 USFDA Observations at Eugia UnitAurobindo Pharma Arm Seals Rs 3,250 Cr Deal to Acquire Khandelwal Labs' Non-Oncology Brands
Alkem Secures CDSCO Panel Approval for Synthetic Semaglutide in Obesity ManagementAlkem Secures CDSCO Panel Approval for Synthetic Semaglutide in Obesity Management
X